US Stock MarketDetailed Quotes

FBRX Forte Biosciences

Watchlist
  • 21.710
  • +1.920+9.70%
Close Nov 29 13:00 ET
  • 21.710
  • 0.0000.00%
Post 17:01 ET
31.74MMarket Cap-1325P/E (TTM)

Forte Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-64.57%16.36M
-19.48%24.5M
-15.20%30.44M
-9.67%37.13M
-9.67%37.13M
4.85%46.19M
-21.07%30.43M
-10.32%35.9M
-2.25%41.1M
-2.25%41.1M
-Cash and cash equivalents
-22.61%16.36M
19.86%24.5M
-15.20%30.44M
-70.90%11.96M
-70.90%11.96M
-52.00%21.14M
-46.98%20.44M
-10.32%35.9M
-2.25%41.1M
-2.25%41.1M
-Short-term investments
----
----
----
--25.16M
--25.16M
--25.04M
--9.99M
----
----
----
Prepaid assets
25.27%1.03M
366.32%900K
217.31%825K
204.11%1.04M
204.11%1.04M
92.74%823K
-5.39%193K
-9.41%260K
-11.89%341K
-11.89%341K
Other current assets
191.49%274K
142.64%313K
113.76%233K
135.71%165K
135.71%165K
-21.01%94K
37.23%129K
22.47%109K
-21.35%70K
-21.35%70K
Total current assets
-62.49%17.67M
-16.38%25.71M
-13.15%31.5M
-7.67%38.33M
-7.67%38.33M
5.62%47.1M
-20.85%30.75M
-10.24%36.27M
-2.37%41.51M
-2.37%41.51M
Non current assets
Net PPE
-12.24%86K
220.00%96K
--106K
--109K
--109K
--98K
--30K
----
--0
--0
-Gross PPE
--124K
--124K
--124K
--118K
--118K
----
----
----
--0
--0
-Accumulated depreciation
---38K
---28K
---18K
---9K
---9K
----
----
----
--0
--0
Non current prepaid assets
-78.61%135K
-43.09%214K
-16.94%353K
3.81%491K
3.81%491K
21.11%631K
-56.33%376K
-51.70%425K
-38.81%473K
-38.81%473K
Other non current assets
18.75%57K
83.87%57K
366.67%56K
307.69%53K
307.69%53K
269.23%48K
138.46%31K
-7.69%12K
0.00%13K
0.00%13K
Total non current assets
-64.22%278K
-16.02%367K
17.85%515K
34.36%653K
34.36%653K
45.51%777K
-50.00%437K
-51.06%437K
-38.17%486K
-38.17%486K
Total assets
-62.52%17.95M
-16.37%26.08M
-12.78%32.02M
-7.18%38.98M
-7.18%38.98M
6.10%47.88M
-21.49%31.18M
-11.13%36.71M
-3.02%42M
-3.02%42M
Liabilities
Current liabilities
Payables
-3.64%5.16M
75.48%5.28M
25.56%1.69M
23.50%1.42M
23.50%1.42M
349.54%5.35M
330.66%3.01M
132.99%1.34M
21.88%1.15M
21.88%1.15M
-accounts payable
-3.64%5.16M
75.48%5.28M
25.56%1.69M
23.50%1.42M
23.50%1.42M
349.54%5.35M
330.66%3.01M
132.99%1.34M
21.88%1.15M
21.88%1.15M
Current accrued expenses
73.80%2.2M
3.85%2.81M
-61.25%813K
14.00%1.3M
14.00%1.3M
175.43%1.27M
648.75%2.7M
553.58%2.1M
767.18%1.14M
767.18%1.14M
Current liabilities
14.84%8.58M
44.71%9.12M
-11.38%3.33M
15.32%3.67M
15.32%3.67M
225.82%7.47M
316.39%6.3M
199.36%3.76M
80.83%3.18M
80.83%3.18M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
14.84%8.58M
44.71%9.12M
-11.38%3.33M
15.32%3.67M
15.32%3.67M
225.82%7.47M
316.39%6.3M
199.36%3.76M
80.83%3.18M
80.83%3.18M
Shareholders'equity
Share capital
-97.22%1K
71.43%36K
71.43%36K
71.43%36K
71.43%36K
71.43%36K
40.00%21K
40.00%21K
40.00%21K
40.00%21K
-common stock
-97.22%1K
71.43%36K
71.43%36K
71.43%36K
71.43%36K
71.43%36K
40.00%21K
40.00%21K
40.00%21K
40.00%21K
Retained earnings
-30.36%-146.84M
-34.82%-138.45M
-34.27%-125.94M
-36.16%-118.52M
-36.16%-118.52M
-37.10%-112.65M
-30.38%-102.69M
-23.85%-93.8M
-18.97%-87.04M
-18.97%-87.04M
Paid-in capital
2.08%156.21M
21.82%155.38M
21.99%154.59M
22.21%153.79M
22.21%153.79M
22.44%153.03M
9.06%127.56M
9.47%126.72M
9.72%125.84M
9.72%125.84M
Gains losses not affecting retained earnings
120.00%1K
-800.00%-7K
---2K
--4K
--4K
---5K
--1K
----
--0
--0
Total stockholders'equity
-76.82%9.37M
-31.84%16.96M
-12.94%28.69M
-9.03%35.31M
-9.03%35.31M
-5.67%40.41M
-34.87%24.88M
-17.73%32.95M
-6.57%38.82M
-6.57%38.82M
Total equity
-76.82%9.37M
-31.84%16.96M
-12.94%28.69M
-9.03%35.31M
-9.03%35.31M
-5.67%40.41M
-34.87%24.88M
-17.73%32.95M
-6.57%38.82M
-6.57%38.82M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -64.57%16.36M-19.48%24.5M-15.20%30.44M-9.67%37.13M-9.67%37.13M4.85%46.19M-21.07%30.43M-10.32%35.9M-2.25%41.1M-2.25%41.1M
-Cash and cash equivalents -22.61%16.36M19.86%24.5M-15.20%30.44M-70.90%11.96M-70.90%11.96M-52.00%21.14M-46.98%20.44M-10.32%35.9M-2.25%41.1M-2.25%41.1M
-Short-term investments --------------25.16M--25.16M--25.04M--9.99M------------
Prepaid assets 25.27%1.03M366.32%900K217.31%825K204.11%1.04M204.11%1.04M92.74%823K-5.39%193K-9.41%260K-11.89%341K-11.89%341K
Other current assets 191.49%274K142.64%313K113.76%233K135.71%165K135.71%165K-21.01%94K37.23%129K22.47%109K-21.35%70K-21.35%70K
Total current assets -62.49%17.67M-16.38%25.71M-13.15%31.5M-7.67%38.33M-7.67%38.33M5.62%47.1M-20.85%30.75M-10.24%36.27M-2.37%41.51M-2.37%41.51M
Non current assets
Net PPE -12.24%86K220.00%96K--106K--109K--109K--98K--30K------0--0
-Gross PPE --124K--124K--124K--118K--118K--------------0--0
-Accumulated depreciation ---38K---28K---18K---9K---9K--------------0--0
Non current prepaid assets -78.61%135K-43.09%214K-16.94%353K3.81%491K3.81%491K21.11%631K-56.33%376K-51.70%425K-38.81%473K-38.81%473K
Other non current assets 18.75%57K83.87%57K366.67%56K307.69%53K307.69%53K269.23%48K138.46%31K-7.69%12K0.00%13K0.00%13K
Total non current assets -64.22%278K-16.02%367K17.85%515K34.36%653K34.36%653K45.51%777K-50.00%437K-51.06%437K-38.17%486K-38.17%486K
Total assets -62.52%17.95M-16.37%26.08M-12.78%32.02M-7.18%38.98M-7.18%38.98M6.10%47.88M-21.49%31.18M-11.13%36.71M-3.02%42M-3.02%42M
Liabilities
Current liabilities
Payables -3.64%5.16M75.48%5.28M25.56%1.69M23.50%1.42M23.50%1.42M349.54%5.35M330.66%3.01M132.99%1.34M21.88%1.15M21.88%1.15M
-accounts payable -3.64%5.16M75.48%5.28M25.56%1.69M23.50%1.42M23.50%1.42M349.54%5.35M330.66%3.01M132.99%1.34M21.88%1.15M21.88%1.15M
Current accrued expenses 73.80%2.2M3.85%2.81M-61.25%813K14.00%1.3M14.00%1.3M175.43%1.27M648.75%2.7M553.58%2.1M767.18%1.14M767.18%1.14M
Current liabilities 14.84%8.58M44.71%9.12M-11.38%3.33M15.32%3.67M15.32%3.67M225.82%7.47M316.39%6.3M199.36%3.76M80.83%3.18M80.83%3.18M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 14.84%8.58M44.71%9.12M-11.38%3.33M15.32%3.67M15.32%3.67M225.82%7.47M316.39%6.3M199.36%3.76M80.83%3.18M80.83%3.18M
Shareholders'equity
Share capital -97.22%1K71.43%36K71.43%36K71.43%36K71.43%36K71.43%36K40.00%21K40.00%21K40.00%21K40.00%21K
-common stock -97.22%1K71.43%36K71.43%36K71.43%36K71.43%36K71.43%36K40.00%21K40.00%21K40.00%21K40.00%21K
Retained earnings -30.36%-146.84M-34.82%-138.45M-34.27%-125.94M-36.16%-118.52M-36.16%-118.52M-37.10%-112.65M-30.38%-102.69M-23.85%-93.8M-18.97%-87.04M-18.97%-87.04M
Paid-in capital 2.08%156.21M21.82%155.38M21.99%154.59M22.21%153.79M22.21%153.79M22.44%153.03M9.06%127.56M9.47%126.72M9.72%125.84M9.72%125.84M
Gains losses not affecting retained earnings 120.00%1K-800.00%-7K---2K--4K--4K---5K--1K------0--0
Total stockholders'equity -76.82%9.37M-31.84%16.96M-12.94%28.69M-9.03%35.31M-9.03%35.31M-5.67%40.41M-34.87%24.88M-17.73%32.95M-6.57%38.82M-6.57%38.82M
Total equity -76.82%9.37M-31.84%16.96M-12.94%28.69M-9.03%35.31M-9.03%35.31M-5.67%40.41M-34.87%24.88M-17.73%32.95M-6.57%38.82M-6.57%38.82M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data